Lamisil (Terbinafine)

Terbinafine blocks the fungal enzyme squalene epoxidase, preventing the synthesis of ergosterol, a vital component of fungal cell membranes. Without ergosterol, the fungal cell membrane becomes defective, leading to accumulation of toxic substances and ultimately fungal cell death.

The specific dose and duration of Lamisil are determined by the prescribing healthcare professional based on the type and severity of the infection, the area of skin involved, and patient factors. Patients should follow the prescriber’s instructions and the product label.

Safety data for topical terbinafine in pregnancy and lactation are limited. Healthcare providers should weigh the potential benefits against any possible risks before prescribing Lamisil to pregnant or nursing individuals. Patients should discuss their situation with a qualified professional.

To request Lamisil, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide. After submission, the sales team will verify trade or institutional credentials and respond with pricing, availability, shipping details and any required import documentation.

Lamisil (terbinafine) belongs to the allylamine class, which differs from azole antifungals that inhibit lanosterol 14α‑demethylase. Terbinafine often provides rapid fungicidal activity and may require shorter treatment courses for certain skin infections, while azoles are typically fungistatic and may be used for a broader range of fungal species.

Store Lamisil at room temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture, excessive heat and direct sunlight to maintain its stability and effectiveness.

Apply a thin layer of the cream or gel to the affected skin area once or twice daily, as directed by the prescriber. Wash and dry the area before application, and avoid covering the treated skin with airtight dressings unless instructed otherwise.

While rare, serious adverse reactions can include severe allergic responses such as angioedema, anaphylaxis, Stevens‑Johnson syndrome, or toxic epidermal necrolysis. Patients should seek immediate medical attention if they experience swelling of the face, lips, tongue, or widespread skin blistering.

Individuals with a known hypersensitivity to terbinafine, other allylamine antifungals, or any component of the formulation should avoid using Lamisil. It is also contraindicated on severely damaged or broken skin and should be used with caution in patients with extensive skin involvement.